Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Freeze-dried Rabies Human Diploid Cell Vaccine
ChiCTR-PIR-16008129Phase 3Recruiting
- Sponsor
- Zhejiang Provincial Center for Disease Control and Prevention
- Start
- Mar 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of rabies virus inactivated antigen, B in rabies (2 arms), sponsored by Zhejiang Provincial Center for Disease Control and Prevention. Primary endpoints: Rabies virus neutralizing antibody concentration and Percentages of subjects reporting adverse reactions. Started Mar 2016; status: recruiting.
02
Drugs
rabies virus inactivated antigen, B
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR-PIR-16008129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PIR-16008129.